Compare · MASS vs TMO
MASS vs TMO
Side-by-side comparison of 908 Devices Inc. (MASS) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MASS and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $183.60B, about 562.6x MASS ($326.3M).
- Over the past year, MASS is up 43.8% and TMO is up 24.5% - MASS leads by 19.3 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 9 for MASS).
- TMO has more recent analyst coverage (25 ratings vs 5 for MASS).
- Company
- 908 Devices Inc.
- Thermo Fisher Scientific Inc
- Price
- $8.56+1.48%
- $493.55+0.20%
- Market cap
- $326.3M
- $183.60B
- 1M return
- +25.59%
- +2.96%
- 1Y return
- +43.83%
- +24.50%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 9
- 17
- Recent ratings
- 5
- 25
908 Devices Inc.
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest MASS
- Large owner Awm Investment Company, Inc. sold $1,612,091 worth of 908 DEVICES (186,942 units at $8.62) (SEC Form 4)
- Director Brown Christopher D. sold $270,000 worth of shares (30,000 units at $9.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 895,559 units (SEC Form 4)
- Chief Financial Officer Griffith Joseph H. Iv sold $62,668 worth of shares (6,940 units at $9.03) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 132,956 units (SEC Form 4)
- SEC Form 144 filed by 908 Devices Inc.
- SEC Form SD filed by 908 Devices Inc.
- 908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference
- Amendment: SEC Form SCHEDULE 13G/A filed by 908 Devices Inc.
- Large owner Awm Investment Company, Inc. sold $41,257 worth of shares (5,000 units at $8.25) (SEC Form 4)
- SVP, Sales & Product Marketing Kenneweg John sold $148,048 worth of shares (18,255 units at $8.11), decreasing direct ownership by 24% to 57,784 units (SEC Form 4)
- Large owner Awm Investment Company, Inc. sold $632,130 worth of 908 DEVICES (78,209 units at $8.08) (SEC Form 4)
Latest TMO
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)
- Director Johnson Jennifer M was granted 499 shares, increasing direct ownership by 55% to 1,403 units (SEC Form 4)
- Director Jacks Tyler was granted 499 shares, increasing direct ownership by 6% to 9,462 units (SEC Form 4)